Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Orthopaedic Science
Published in: Journal of Orthopaedic Science 5/2015

01-09-2015 | Case Report

Reossification of osteolytic metastases at the acetabulum following gefitinib and multidisciplinary treatment for lung cancer: a case report with autopsy findings

Authors: Yasuzumi Kishimoto, Toshiki Iwase, Toshiaki Yano, Hiroki Mori

Published in: Journal of Orthopaedic Science | Issue 5/2015

Login to get access

Excerpt

Patients with bone metastases often suffer from skeletal-related events (SREs), which result in increased pain, impaired mobility, and a reduced quality of life (QoL). Some previous studies have shown that gefitinib treatment leads to a reduction in osteolytic metastases, as determined by radiological examinations and the level of pain experienced on movement [1, 2]. However, to the best of our knowledge, no pathological analysis of the reduction of an osteolytic lesion has previously been reported. Here we present the case of a woman with osteolytic metastasis in the acetabulum who reacquired pain-free mobility after gefitinib and multidisciplinary treatment for lung adenocarcinoma harboring epidermal growth factor receptor (EGFR) mutation. Very early osteosclerotic change in the acetabular osteolytic lesion was identified on radiological examination, and its reossification was apparent upon pathological analysis. …
Literature
1.
Zukawa M, Nakano M, Hirano N, Mizuhashi K, Kanamori M. The effectiveness of gefitinib on spinal metastases of lung cancer—report of two cases. Asian Spine J. 2008;2:109–13.PubMedCentralCrossRefPubMed
2.
Yamashita Y, Aoki T, Hanagiri T, Yoshii C, Mukae H, Uramoto H, Korogi Y. Osteosclerotic lesions in patients treated with gefitinib for lung adenocarcinomas: a sign of favorable therapeutic response. Skelet Radiol. 2012;41:409–14.CrossRef
3.
Kijima T, Fujii Y, Suyama T, Okubo Y, Yonese J, Fukui I. Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report. Int J Urol. 2008;15:546–7.CrossRefPubMed
4.
Osanai T, Tsuchiya T, Ogino T, Nakahara K. Long-term prevention of skeletal complications by pamidronate in a patient with bone metastasis from endometrial carcinoma: a case report. Gynecol Oncol. 2006;100:195–7.CrossRefPubMed
5.
Normanno N, De Luca, Aldinucci D, Maiello MR, Mancino M, D’Antonio A, De Filippi R, Pinto A. Gefitinib inhibits the ability of human bone marrow stromal cells to reduce osteoclast differentiation; implications for the pathologenesis and treatment of bone metastasis. Endocr Ralat Cancer. 2005;12:471–82.CrossRef
6.
Normanno N, Gullick WJ. Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application? Endocr Relat Cancer. 2006;13:3–6.CrossRefPubMed
7.
Mitsudomi T, Yatabe Y. Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Cancer sci. 2007;98:1817–24.CrossRefPubMed
8.
Clézardin P, Fournier P, Boissier S, Peyruchaud O. In vitro and in vivo antitumor effects of bisphosphonates. Curr Med Chem. 2003;10:173–80.CrossRefPubMed
9.
Koto K, Horie N, Kimura S, Murata H, Sakabe T, Matsui T, Watanabe M, Adachi S, Maekawa T, Fushiki S, Kubo T. Clinically relevant dose of zoledronic acid inhibits spontaneous lung metastasis in a murine osteosarcoma model. Cancer Lett. 2009;274:271–8.CrossRefPubMed
10.
Koto K, Murata H, Kimura S, Horie N, Matsui T, Nishigaki Y, Ryu K, Sakabe T, Ashihara E, Maekawa T, Fushiki S, Kubo T. Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents. Oncol Rep. 2010;24:233–9.PubMed
11.
Krempien R, Huber PE, Harms W, Treiber M, Wannenmacher M, Krempien B. Combination of early bisphosphonate administration and irradiation leads to improved remineralization and restabilization of osteolytic bone metastases in an animal tumor model. Cancer. 2003;98:1318–24.CrossRefPubMed
12.
Kijima T, Fujii Y, Suyama T, Okubo Y, Yamamoto S, Masuda H, Yonese J, Fukui I. Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate. BJU Int. 2009;103:620–4.CrossRefPubMed
13.
Ricciardi S, de Marinis F. Treatment of bone metastases in lung cancer: the actual role of zoledronic acid. Rev Recent Clin Trials. 2009;4:205–11.CrossRefPubMed
14.
Moore KL, Persaud TVN, Torchia MG. Skeletal system. The developing human. 9th ed. Philadelphia: Elsevier; 2013. p. 343–61.
15.
Kierszenbaum AL, Tres LL. Oeteogenesis. Histology and Cell Biology: an introduction to Pathology. 3rd ed. Philadelphia: Elsevier; 2012. p. 151–68.CrossRef
Metadata
Title
Reossification of osteolytic metastases at the acetabulum following gefitinib and multidisciplinary treatment for lung cancer: a case report with autopsy findings
Authors
Yasuzumi Kishimoto
Toshiki Iwase
Toshiaki Yano
Hiroki Mori
Publication date
01-09-2015
Publisher
Springer Japan
Published in
Journal of Orthopaedic Science / Issue 5/2015
Print ISSN: 0949-2658
Electronic ISSN: 1436-2023
DOI
https://doi.org/10.1007/s00776-014-0562-y

Other articles of this Issue 5/2015

Journal of Orthopaedic Science 5/2015 Go to the issue

Original Article

Diagnostic accuracy of the Self-administered, Self-reported History Questionnaire for lumbar spinal stenosis patients in Japanese primary care settings: a multicenter cross-sectional study (DISTO-project)

Original Article

Risk factors for limb overgrowth after the application of titanium elastic nailing in the treatment of pediatric femoral fracture

Original Article

Early results after modular non-cemented reverse total shoulder arthroplasty: a prospective single-centre study of 38 consecutive cases

Case Report

Intramedullary cervicothoracic subependymoma: report of three cases and review of the literature

Original Article

Half-peroneus-longus-tendon graft augmentation for unqualified hamstring tendon graft of anterior cruciate ligament reconstruction

Case Report

An acute case of paraplegia and spinal bronchogenic cyst